[Federal Register Volume 71, Number 141 (Monday, July 24, 2006)]
[Notices]
[Page 41841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-11690]
[[Page 41841]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 20, 2006, and published in the Federal
Register on March 27, 2006, (71 FR 15219), Organichem Corporation, 33
Riverside Avenue, Rensselaer, New York 12144, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances
listed in Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Dextropropoxyphene (9273).................. II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers. In
reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabindiol as a synthetic intermediate. This controlled
substance will be further synthesized to bulk manufacture a synthetic
THC (7370). No other activity for this drug code is authorized for this
registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Organichem Corporation to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Organichem Corporation to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-11690 Filed 7-21-06; 8:45 am]
BILLING CODE 4410-09-P